Illumina woes shine light on industry trouble
October 07, 2011 at 13:50 PM EDT
A revenue warning from biotechnology firm Illumina causes shares to tank — and takes a bite out of the market caps of other players in the industry.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|